- Home
- PCVX vs HTGC Comparison
PCVX vs HTGC Comparison
Compare PCVX & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCVX | HTGC |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 3.2B |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PCVX | HTGC |
|---|---|---|
| Price | $46.57 | $18.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $101.67 | $21.13 |
| AVG Volume (30 Days) | ★ 1.5M | 1.3M |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 9.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $516,847,000.00 |
| Revenue This Year | N/A | $8.72 |
| Revenue Next Year | N/A | $9.57 |
| P/E Ratio | ★ N/A | $10.83 |
| Revenue Growth | N/A | ★ 4.54 |
| 52 Week Low | $27.66 | $15.65 |
| 52 Week High | $94.60 | $22.04 |
Technical Indicators
Market Signals| Indicator | PCVX | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 71.21 |
| Support Level | $43.78 | $17.86 |
| Resistance Level | $48.11 | $17.67 |
| Average True Range (ATR) | 1.99 | 0.30 |
| MACD | -0.49 | 0.18 |
| Stochastic Oscillator | 42.99 | 94.21 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.